Financials data is unavailable for this security.
View more
Year on year Bergenbio ASA had revenues fall -9.00% from 389.00k to 354.00k, though the company grew net income from a loss of 302.12m to a smaller loss of 190.40m.
Gross margin | -- |
---|---|
Net profit margin | -29,828.21% |
Operating margin | -31,124.18% |
Return on assets | -67.73% |
---|---|
Return on equity | -85.55% |
Return on investment | -85.55% |
More ▼
Cash flow in NOKView more
In 2023, Bergenbio ASA did not generate a significant amount of cash. Cash Flow from Financing totalled 224.88m or 63,526.55% of revenues. In addition the company used 225.10m for operations while cash from investing totalled 3.06m.
Cash flow per share | -5.37 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.48 |
---|---|
Tangible book value per share | 4.48 |
More ▼
Balance sheet in NOKView more
Current ratio | 5.05 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼